Case Studies
Representative project outcomes across clinical, manufacturing, and data integrity environments.
Client Profile
Biotech sponsor (Phase II, China multi-center)
Challenge
Inconsistent site documentation quality and delayed deviation closure.
Our Action
Risk-ranked site audit + TMF traceability review + focused CAPA workshop for sponsor and CRO teams.
Outcome
Critical finding closure cycle reduced from 45 to 18 days before regulatory interaction.
Client Profile
Commercial-stage pharma manufacturer
Challenge
High pressure pre-inspection readiness with cross-function evidence gaps.
Our Action
Simulated inspection room, interview rehearsal, and evidence map by process owner.
Outcome
Inspection response alignment improved and major observation risk areas were pre-closed.
Client Profile
Global study support platform
Challenge
Audit trail governance and Part 11 evidence chain not consistently controlled.
Our Action
ALCOA+ diagnostic, role-based control redesign, and validation documentation refresh.
Outcome
Digital compliance baseline stabilized with clear ownership and periodic verification rhythm.
Our case execution model is designed with benchmark awareness from global quality leaders and adapted for China operational realities.
Share your current inspection or quality pressure point. We will propose a scoped action path.
Talk to Our Team